Economic evaluation of treatment administration strategies of ganciclovir for cytomegalovirus retinitis in HIV/AIDS patients in Thailand: a simulation study. Teerawattananon K1, Iewsakul S1, Yenjitr C2, Ausayakhun S3, Yenjitr W4, Mugford M5, Teerawattananon Y2,6. 1 Ophthalmology Unit, Chiangkh

A collaborative study was conducted by representatives from the Ministry of Health’s Directorate of Non – Communicable Disease (NCD) Control and the National Institute of Health Research and Development (NIHRD), the WHO Indonesia office, the WHO Southeast Asia Regional Office, and the Health Interve

Abstract Background This study aims to assess the cost-effectiveness and budget impact of adopting sildenafil to the benefits package for the indication of pulmonary arterial hypertension (PAH), compared to beraprost. Methods Based on a societal perspective, a model-based economic evaluation

This study consists of two sub-studies as follows: Sub-study 1) Development of guidelines defining targets and indicators of Thai Health Promotion Foundation (ThaiHealth) using data from the cost of illness studies.  In this sub study, incidence-based cost of alcohol drinking and cigarette smoking will be calculated and then used to set the target

Naiyana Praditsitthikorn BSc(Pharm), PhD*,** * Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand ** Bureau of AIDS TB and STIs, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand There is an increasing number of at

Abstract Background: Diarrhoea remains one of the top ten causes of under-five child morbidity in Bhutan, and rotavirus is a significant cause of child diarrhoeal hospitalisations. This study sought to determine the health outcomes, cost-effectiveness, and budget and human resource implications o

Economic Evaluation of Rehabilitation Services for Inpatients with Stroke in Thailand: A Prospective Cohort Study. Orathai Khiaocharoen, BN, PhD1, , , , Supasit Pannarunothai, MD, PhD2, Wachara Riewpaiboon,MD3, Lily Ingsrisawang, BSc, PhD4, Yot Teerawattananon, MD, PhD5 1 Hea

Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand Naiyana Praditsitthikorn,1,2 Yot Teerawattananon,1,3 Sripen Tantivess,1,3 Supon Limwattananon,3 Arthorn Riewpaiboon,2 Saibua Chichareon,4 Nantakan Ieumwananonthachai5 and Viroj Tangcharoensathien3

Abstract Objectives This study aims to assess the value for money and budget impact of offering hemodialysis (HD) as a first-line treatment, or the HD-first policy, and the peritoneal dialysis (PD) first policy compared to a supportive care option in patients with end-stage renal disease (ESRD)

Abstract BACKGROUND: Pegylated interferon alpha 2a, alpha 2b and ribavirin have been included to the National List of Essential Medicines (NLEM) for treatment of only chronic hepatitis C genotypes 2 and 3 in Thailand. This reimbursement policy has not covered for other genotypes of hepatitis